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Background: We examined the associations between thigh muscle area (TMA) and insulin resistance (IR) according to body 
mass index (BMI) in middle-aged Korean general population.
Methods: TMA was measured using quantitative computed tomography and corrected by body weight (TMA/Wt) in 1,263 men, 
788 premenopausal women, and 1,476 postmenopausal women all aged 30 to 64 years. The tertiles of TMA/Wt were calculated 
separately for men and for premenopausal and postmenopausal women. Homeostatic model assessment for insulin resistance 
(HOMA-IR) was performed using fasting blood glucose and insulin levels, and increased IR was defined according to sex-specif-
ic, top quartiles of HOMA-IR. Associations between the TMA/Wt tertiles and increased IR according to the BMI categories (<25 
and ≥25 kg/m2) were assessed using multivariable logistic regression analysis. 
Results: In men with higher BMIs, but not in those with lower BMIs, the presence of an increased IR had significantly higher odds 
ratios in the lower TMA/Wt tertiles, even after adjustment for visceral fat area. However, in premenopausal and postmenopausal 
women, there was no significant inverse association between TMA/Wt tertiles and increased IR, regardless of BMI category. 
Conclusion: Our findings suggest that the thigh muscle is inversely associated with IR in men, particularly in those with higher 
BMIs.
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INTRODUCTION
Sarcopenia, the degenerative loss of skeletal muscle mass, 
could be associated with a cardio-metabolic risk, metabolic 
disease, and psychological disorders [1-3]. Many studies have 
reported a significant inverse association between muscle mass 
and insulin resistance (IR). However, most of these studies 
were conducted in older adults or people with chronic condi-
tions, such as diabetes mellitus, chronic obstructive pulmonary 
disease, or end-stage renal disease [4-8]. Some studies have 
been conducted in general populations [2,4,8-11], but only few 
of them targeted middle-aged population [2,11]. And the re-
sults were inconsistent. One study found a significant associa-
tion between low muscle mass and higher IR in a middle-aged 
population [11]. Another noted a significant association be-
tween low muscle mass and higher IR in an older adult popu-
lation, but was unable to document the same association in a 
middle-aged population [2]. Although the initiation of muscle 
decline starts in the middle age, little information is available 
regarding the independent impact of low muscle mass and IR 
in the middle-aged general population. 




pISSN 2233-6079 · eISSN 2233-6087
Diabetes Metab J 2020;44:446-457
Thigh muscle and insulin resistance 
447Diabetes Metab J 2020;44:446-457 https://e-dmj.org
sumption, exercise, and protein intake, could be determinants 
of decreases in muscle mass and function, and age-related 
muscle decline could be more prominent in men than in wom-
en [12]. Although many characteristics differ between men 
and women, most studies on associations between muscle 
mass and IR have only addressed these differences in their 
analyses by adjustment, instead of stratification. Also, previous 
studies have demonstrated different trends in muscle and obe-
sity indicators, including visceral fat, according to the meno-
pausal status of women [13]. These differences according to 
sex and menopausal status could modify the relationships be-
tween muscle mass and IR, but there are not enough studies 
and the mechanisms are not well established. In addition, it 
should be investigated whether the impacts of the muscle mass 
on IR are independent from those of known risk factors, in-
cluding lifestyle factors and obesity status [14-16]. 
Accordingly, we sought to evaluate the independent rela-
tionship between thigh muscle area (TMA) measured using 
quantitative computed tomography (QCT) and IR according 
to different body mass index (BMI) categories in middle-aged, 




The present study utilized data from the Cardiovascular and 
Metabolic Disease Etiology Research Center (CMERC) cohort 
study, which was designed to recruit members of the general 
population residing in four districts (Seoul, Goyang, Gimpo, 
and Incheon) in South Korea. The inclusion criteria were 30 to 
64 years of age, residing more than 8 months of the year at cur-
rent residence with no plans to move over the next 2 years, and 
having the ability to provide verbal or written consent to par-
ticipate in the study. Participants were excluded if they had 
been diagnosed with cancer within the last 2 years or were cur-
rently being treated for cancer; had a history of myocardial in-
farction, stroke, or heart failure; were currently involved in 
pharmaceutical trials; or were currently pregnant or reported 
the possibility of being pregnant on the day of registration. The 
detailed methods for the CMERC cohort study have been re-
ported elsewhere [17]. This study initially enrolled 4,060 par-
ticipants between 2013 and 2017. All participants completed 
health questionnaires and examinations according to a pre-
defined protocol. Those with missing TMA variables (n=268), 
those who were treated for diabetes mellitus (n=190), and 
those with a BMI under 18.5 kg/m2 (n=75) were excluded 
from the current analysis. Finally, a cross-sectional analysis 
was conducted of the remaining 1,263 men, 788 premeno-
pausal women, and 1,476 postmenopausal women. All partici-
pants provided written informed consent, and the study proto-
col was approved by the Institutional Review Board of Sever-
ance Hospital at Yonsei University College of Medicine (IRB 
No. 4-2013-0661).
Measurements
All participants were individually interviewed using standard-
ized questionnaires to obtain information regarding demo-
graphics, health behaviors, and medication use. Trained inter-
viewers conducted face-to-face interviews and administered 
questionnaires according to a standard protocol. Health be-
haviors included smoking status (current smoker, former 
smoker, or non-smoker), alcohol intake (current heavy drink-
er, current non-heavy drinker, former drinker, or non-drink-
er), physical activity, and sleep duration. Average alcohol con-
sumption (in grams per drinking day) was calculated using the 
average number of alcoholic beverages consumed and the fre-
quency of alcohol consumption, and then converted into the 
amount of ethanol in grams. Current heavy drinking was de-
fined as drinking >40 g ethanol per drinking day for men and 
>20 g per drinking day for women for two or more times a 
week [18]. Physical activity was assessed using the Internation-
al Physical Activity Questionnaire-Short Form. For this study, 
high activity referred to activities that considerably increased 
an individual’s respiratory effort, whereas moderate activity re-
ferred to those that moderately increased respiratory effort. 
Regular exercise was defined as moderate-to-high-intensity 
physical activity performed at least three times per week. Sleep 
duration was recorded in hours per day (hr/day) and as the av-
erage over the past year. Medication use (antihypertensive and 
lipid-lowering) was assessed by self-reports.
The study participants wore lightweight clothing for conve-
nient and reliable examinations. BMI was calculated as the 
body weight divided by the standing height squared (kg/m2). 
Waist circumference was assessed to the nearest 0.1 cm at the 
midpoint between the lower border of the rib cage and the iliac 
crest using an ergonomic circumference-measuring tape 
(SECA 201; SECA, Hamburg, Germany). Participants rested 
for 5 minutes before the blood pressure measurement, and sys-
tolic and diastolic blood pressures were repeatedly measured 
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three times at 2-minute intervals. The average of the second 
and third measurements was used for analysis. Hypertension 
was defined as a systolic blood pressure ≥140 mm Hg, diastol-
ic blood pressure ≥90 mm Hg, or a self-report of current use 
of an antihypertensive medication.
Blood samples were collected from the antecubital vein after 
the patients had fasted for at least 8 hours. Fasting blood glu-
cose concentrations were measured using a colorimetry meth-
od (ADVIA 1800 Auto Analyzer; Siemens Medical Solutions, 
Malvern, PA, USA). Serum insulin concentrations were mea-
sured with a radioimmunoassay (SR-300; Stratec, Birkenfeld, 
Germany). Glycosylated hemoglobin concentrations were as-
sessed using high-performance liquid chromatography (Vari-
ant II TURBO; Bio-Rad, Berkeley, CA, USA) according to the 
National Glycohemoglobin Standardization Program guide-
lines. IR was evaluated using the homeostasis model assess-
ment of IR (HOMA-IR) and was calculated as follows: fasting 
plasma glucose (mg/dL)×fasting plasma insulin (mIU/mL)/ 
405 [19]. Increased IR was defined as ranking in the top 25th 
percentile of HOMA-IR values separately for men (≥2.711), 
premenopausal women (≥2.148), and postmenopausal wom-
en (≥2.318) [20]. Pre-diabetes was defined as a fasting glucose 
level of 100 to 126 mg/dL or a glycosylated hemoglobin level of 
5.7 to 6.5% according to the American Diabetes Association 
criteria [21]. Total cholesterol, high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol, and triglyceride lev-
els were measured using enzymatic methods (ADVIA 1800 
Auto Analyzer). Dyslipidemia was defined as a total cholester-
ol level ≥240 mg/dL, or a high-density lipoprotein cholesterol 
level ≤40 mg/dL, or a low-density lipoprotein cholesterol level 
≥160 mg/dL, or a triglycerides level ≥200 mg/dL according to 
the Expert Panel on Detection, Evaluation, and Treatment of 
High Blood Cholesterol in Adults or as people who were tak-
ing lipid-lowering medication. C-reactive protein concentra-
tions were determined with a turbidimetric immunoassay 
(ADVIA 1800 Auto Analyzer). 
TMA and visceral fat area were measured by QCT using a 
Somatom Definition AS+ 128-channel CT (Siemens Health-
care, Forchheim, Germany), a Somatom sensation 64-channel 
CT (Siemens Healthcare), or a GE Lightspeed VCT scanner 
(General Electric Medical System, Milwaukee, WI, USA). 
Scanning was performed at 120 kVp and 150 mAs and a pitch 
of 1.0. Images were reconstructed with a 3-mm slice thickness. 
Voxels were separated into fat and muscle tissue according to 
Hounsfield units (HU): –190 to –30 HU for fat and 30 to 100 
HU for muscle. All scanned data were analyzed using Aquarius 
intuition Viewer version 4.4.12 software (Terarecon, Foster 
City, CA, USA). TMA was recorded as the mean of right and 
left TMA values. TMA was found to be correlated with body 
size (r=0.566 in men, r=0.491 in premenopausal women, and 
r=0.463 in postmenopausal women), indicating that partici-
pants with a larger body size may have larger TMA. Therefore, 
TMA was corrected by body weight (TMA/Wt, cm2/kg) [22]. 
The participants were divided into three groups according to 
sex and menopausal-specific TMA/Wt tertiles: <338.9, 338.9–
377.7, and ≥377.8 for men; <276.5, 276.5–309.1, and ≥309.2 
for premenopausal women; and <261.0, 261.0–292.4, and 
≥292.5 for postmenopausal women. 
Statistical analysis
We evaluated differences in demographic characteristics 
among the three groups based on the TMA/Wt tertiles, and we 
used one-way analysis of variance for normally distributed 
variables, Kruskal-Wallis test for skewed variables, and chi-
square test for categorical variables. The P for trend was calcu-
lated using a contrast to test for linear trends in continuous 
variables and the Cochran-Armitage test for categorical vari-
ables. 
Multivariable logistic regression analyses were used to assess 
independent associations between TMA/Wt (using tertiles and 
continuous variables) and the likelihood of an increased IR in 
three adjusted models: [1] adjusted for age; [2] additionally ad-
justed for systolic blood pressure, triglyceride level, smoking, 
alcohol intake, exercise, and sleep duration; and [3] additional-
ly adjusted for visceral fat area. We conducted the above-men-
tioned analyses separately for men, premenopausal, and post-
menopausal women, because there were significant interac-
tions between sex and TMA/Wt (P for interaction=0.028) and 
a borderline interaction between menopausal status and 
TMA/Wt (P for interaction=0.065) in the presence of an in-
creased IR and because both TMA/Wt and HOMA-IR signifi-
cantly differed according to sex and menopausal status in 
women (Supplementary Table 1).
The associations between TMA/Wt (using tertiles and con-
tinuous variables) and the likelihood of an increased IR were 
also assessed in people with lower (<25.0 kg/m2) and higher 
BMIs (≥25.0 kg/m2) using the same models. Then, we also an-
alyzed interactions between TMA/Wt tertiles and BMI catego-
ries for the presence of an increased IR in men and in pre-
menopausal and postmenopausal women. All statistical tests 
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were performed using SAS version 9.4 (SAS Institute, Cary, 
NC, USA). Statistical significance was defined as a two-sided P 
value <0.05.
RESULTS
The general characteristics of the study participants are pre-
sented in Supplementary Table 1. This study included 1,263 
men, 788 premenopausal women, and 1,476 postmenopausal 
women, with mean ages of 49.8, 43.0, and 57.1 years, respec-
tively. Both mean TMA/Wt and median HOMA-IR values 
were significantly higher in men than in women. Mean TMA/
Wt was significantly higher in premenopausal than in post-
menopausal women. Conversely, the median HOMA-IR was 
significantly higher in postmenopausal than in premenopausal 
women. 
Table 1 shows the general characteristics of the men accord-
ing to TMA/Wt tertiles. Men in the lower TMA/Wt tertiles 
tended to have higher obesity indices, blood pressure, triglyc-
erides, and HOMA-IR values; higher frequencies of former 
smokers; and higher frequencies of hypertension, pre-diabetes 
mellitus, and dyslipidemia. Tables 2 and 3 show the general 
characteristics of the premenopausal and postmenopausal 
women, respectively, according to TMA/Wt tertiles. Both pre-
menopausal and postmenopausal women in the lower TMA/
Wt tertiles tended to have higher obesity indices, blood pres-
sure, lipid profile, HOMA-IR, C-reactive, and protein levels; 
higher frequencies of hypertension; and lower frequencies of 
regular exercise. Postmenopausal women in the lower TMA/
Wt tertiles tended to have higher frequencies of pre-diabetes 
mellitus and dyslipidemia and lower frequencies of current 
heavy drinking, unlike premenopausal women. 
Table 4 presents the results of the multivariable logistic re-
gression models for the associations between TMA/Wt (as ter-
tiles and continuous variables) and increased IR in men, pre-
menopausal, and postmenopausal women. In men, even after 
adjustment for potential confounders, including visceral fat 
area, the presence of an increased IR was significantly higher 
in the lower TMA/Wt tertile (odds ratio [OR], 1.63; 95% confi-
dence interval [CI], 1.10 to 2.45), but was not significant in the 
middle tertile (OR, 1.05; 95% CI, 0.70 to 1.58), relative to the 
upper tertile. In this model, which included TMA/Wt as a con-
tinuous variable, the multivariable-adjusted OR increased by 
1.06 (95% CI, 1.02 to 1.10) per 10 cm2/kg lower TMA/Wt. 
However, in both premenopausal and postmenopausal wom-
en, an association between TMA/Wt and increased IR was not 
observed after additionally adjustment for visceral fat area. We 
also repeated the analysis using fasting glucose and fasting in-
sulin levels as dependent variables instead of HOMA-IR and 
observed similar results (data not shown).
Table 5 presents the associations between TMA/Wt and in-
creased IR according to the BMI categories in men. Among 
men with lower BMIs, the presence of an increased IR had 
higher, but non-significant, ORs in the lower and middle 
TMA/Wt tertiles. However, among men with higher BMIs, the 
presence of an increased IR showed significantly higher ORs in 
the lower TMA/Wt tertiles than in the upper TMA/Wt tertile. 
There was a significant interaction between the TMA/Wt ter-
tiles and BMI categories in the presence of an increased IR in 
men (P for interaction=0.046).
Conversely, there were no significant associations between 
TMA/Wt and increased IR, regardless of BMI category, in pre-
menopausal and postmenopausal women. Also, there were no 
significant interactions between TMA/Wt tertiles and BMI 
categories in the presence of an increased IR in premenopausal 
(P for interaction=0.093) or postmenopausal (P for interac-
tion=0.853) women (Supplementary Table 2).
DISCUSSION 
The current study found that a lower thigh muscle was inde-
pendently associated with a higher IR, even after adjustment 
for traditional risk factors, in a cohort of middle-aged Korean 
men with higher BMIs, but not in men with lower BMIs. This 
trend was not observed in premenopausal and postmenopaus-
al women, regardless of the BMI category.
Associations between muscle mass and IR have been report-
ed in animal [23] and human studies [1,2,11,24-27], including 
a gene analysis [28]. One of these results is consistent [24] with 
ours, and one is inconsistent [25]. Some studies are incompa-
rable [2,11,26,27] because they did not stratify by the obesity 
status. One study [24] reported that people with a lower mus-
cle mass and higher BMIs had significantly higher ORs for IR, 
particularly in a middle-aged population. Another study [25] 
suggested that people with a lower muscle mass and lower 
BMIs had a significantly higher OR for IR. This inconsistent 
results might be due to not adjusting for central obesity, which 
could be highly correlated with the IR, particularly in the low-
er-BMI population [29]. Other studies [2,11,26,27] had similar 
results with ours; however, comparison is difficult because a 
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stratified analysis according to sex and obesity status was not 
performed in those studies. Although two of them [26,27] 
conducted a longitudinal analysis between low muscle mass 
and higher IR it might be hard to identify an independent ef-
fect of the low muscle because it was not adjusted by the body 
size. Except for one study [26], most previous studies used an 
Table 1. Characteristics in men (n=1,263) according to TMA/Wt tertiles
Variable
TMA/Wt tertiles P for 
difference
P for 
trendLower (<338.9 cm2/kg) Middle (338.9–377.7 cm2/kg) Upper (≥377.8 cm2/kg)
Age, yr 50.3±10.6 50.7±10.1 48.3±10.1 0.002 0.167
BMI, kg/m2 26.3±3.2 24.6±2.4 23.8±2.3 <0.001 <0.001
Waist circumference, cm 91.6±8.0 86.6±5.9 82.3±6.3 <0.001 <0.001
Visceral fat area, cm2 143.6±48.9 118.7±40.8 88.9±36.3 <0.001 <0.001
SBP, mm Hg 128.0±13.5 124.7±13.7 123.0±13.2 <0.001 <0.001
DBP, mm Hg 83.1±10.2 80.5±9.7 79.2±9.7 <0.001 <0.001
Total cholesterol, mg/dL 197.1±35.2 199.9±35.8 196.7±30.9 0.333 0.597
HDL-C, mg/dL 48.9±12.2 50.7±11.7 54.4±12.8 <0.001 <0.001
LDL-C, mg/dL 122.3±32.8 123.9±34.3 120.9±28.1 0.427 0.938
Triglycerides, mg/dL 141.0 (104.0–209.0) 136.0 (97.0–194.0) 117.0 (80.0–163.0) <0.001 <0.001
Fasting glucose, mg/dL 92.0 (86.0–102.0) 91.0 (84.0–99.0) 89.0 (83.0–94.0) <0.001 <0.001
Fasting insulin, uIU/mL 10.3 (7.8–13.7) 8.7 (6.8–10.9) 7.5 (6.0–9.8) <0.001 <0.001
HbA1c, % 5.6 (5.4–5.9) 5.5 (5.3–5.8) 5.4 (5.2–5.6) <0.001 <0.001
HOMA-IR 2.39 (1.74–3.35) 2.00 (1.52–2.58) 1.64 (1.30–2.20) <0.001 <0.001
Increased IR, % 170 (40.4) 92 (21.9) 54 (12.8) <0.001 <0.001
C-reactive protein, mg/L 0.9 (0.5–1.9) 0.7 (0.4–1.3) 0.5 (0.3–1.1) 0.068 0.163
Hypertension 188 (44.7) 132 (31.4) 110 (26.1) <0.001 <0.001
Pre-diabetes mellitus 181 (43.0) 166 (39.4) 111 (26.4) <0.001 <0.001
Dyslipidemia 232 (55.1) 222 (52.7) 155 (36.8) <0.001 <0.001
Antihypertensive medication 97 (23.0) 66 (15.7) 42 (10.0) <0.001 <0.001
Lipid-lowering medication 40 (9.5) 36 (8.6) 23 (5.5) 0.075 0.029
Smoking status 0.042 0.827
   Non-smoker 93 (22.1) 84 (19.9) 115 (27.3)
   Former smoker 197 (46.8) 180 (42.8) 172 (40.9)
   Current smoker 131 (31.1) 157 (37.3) 134 (31.8)
Alcohol intake 0.409 0.231
   Non-drinker 35 (8.3) 24 (5.7) 40 (9.5)
   Former drinker 21 (5.0) 25 (5.9) 27 (6.4)
   Current non-heavy drinker 200 (47.5) 208 (49.4) 186 (44.2)
   Current heavy drinker 165 (39.2) 164 (39.0) 168 (39.9)
Regular exercise 270 (64.1) 267 (63.4) 295 (70.1) 0.082 0.063
Sleep duration, hr/day 6.9±1.2 6.8±1.2 7.0±1.1 0.096 0.601
Values are presented as mean±standard deviation, median (interquartile range), or number (%). P values were derived using the independent t-
test, Wilcoxon rank sum test, or chi-square test. 
TMA, thigh muscle area; Wt, weight; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assess-
ment of insulin resistance; IR, insulin resistance.   
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estimated muscle mass, instead of a measured muscle area.
Unlike previous studies, we measured TMA using QCT in a 
large general population and excluded the potential effect of an-
tidiabetic treatment on the association between thigh muscle 
and IR, excluding the patients who were taking antidiabetic 
medications. We also tried to control for confounders not only 
Table 2. Characteristics in premenopausal women (n=788) according to TMA/Wt tertiles
Variable
TMA/Wt tertiles P for 
difference
P for 
trendLower (<276.5 cm2/kg) Middle (276.5–309.1 cm2/kg) Upper (≥309.2 cm2/kg)
Age, yr 43.6±6.9 43.3±6.9 42.0±7.0 0.019 0.056
BMI, kg/m2 24.4±3.2 22.9±2.6 21.6±2.0 <0.001 <0.001
Waist circumference, cm 80.3±8.1 76.3±6.3 72.3±5.9 <0.001 <0.001
Visceral fat area, cm2 84.20±32.70 75.80±30.70 58.10±25.6 <0.001 <0.001
SBP, mm Hg 113.5±12.7 110.7±12.6 108.6±11.7 <0.001 0.001
DBP, mm Hg 73.8±9.5 72.2±9.0 71.1±8.5 0.001 0.002
Total cholesterol, mg/dL 195.6±32.2 191.1±30.6 188.9±33.8 0.051 0.021
HDL-C, mg/dL 60.8±14.1 61.4±13.9 64.4±15.4 0.011 0.054
LDL-C, mg/dL 117.8±31.2 113.7±27.1 108.2±29.8 0.002 0.004
Triglycerides, mg/dL 93.5 (73.0–123.0) 85.0 (65.0–110.0) 79.0 (59.0–107.0) <0.001 0.004
Fasting glucose, mg/dL 85.0 (80.0–90.0) 86.0 (80.0–91.0) 83.0 (79.0–89.0) 0.002 0.696
Fasting insulin, uIU/mL 8.3 (7.0–10.7) 7.9 (6.6–9.8) 7.1 (6.0–8.8) <0.001 0.002
HbA1c, % 5.4 (5.2–5.6) 5.4 (5.2–5.6) 5.4 (5.2–5.5) 0.622 0.691
HOMA-IR 1.75 (1.43–2.34) 1.69 (1.36–2.21) 1.49 (1.24–1.88) <0.001 0.009
Increased IR, % 82 (31.3) 73 (27.8) 42 (16.0) <0.001 <0.001
C-reactive protein, mg/L 0.6 (0.4–1.3) 0.5 (0.3–1.1) 0.3 (0.2–0.6) <0.001 0.021
Hypertension 33 (12.6) 22 (8.4) 19 (7.2) 0.085 0.035
Pre-diabetes mellitus 55 (21.0) 57 (21.7) 45 (17.1) 0.369 0.265
Dyslipidemia 47 (17.9) 52 (19.8) 45 (17.1) 0.721 0.805
Antihypertensive medication 14 (5.3) 6 (2.3) 8 (3.0) 0.143 0.155
Lipid-lowering medication 3 (1.2) 7 (2.7) 6 (2.3) 0.439 0.357
Smoking status 0.787 0.537
   Non-smoker 237 (90.5) 238 (90.5) 230 (87.5)
   Former smoker 14 (5.3) 14 (5.3) 19 (7.2)
   Current smoker 11 (4.2) 11 (4.2) 14 (5.3)
Alcohol intake 0.022 0.227
   Non-drinker 50 (27.0) 62 (23.0) 60 (18.0)
   Former drinker 2 (1.1) 17 (6.3) 14 (4.2)
   Current non-heavy drinker 112 (60.5) 163(60.4) 209 (62.8)
   Current heavy drinker 21 (11.4) 28 (10.4) 50 (15.0)
Regular exercise 143 (54.6) 155 (58.9) 177 (67.3) 0.011 0.003
Sleep duration, hr/day 6.9±1.3 7.0±1.2 7.0±1.2 0.712 0.421
Values are presented as mean±standard deviation, median (interquartile range), or number (%). P values were derived using the independent t-
test, Wilcoxon rank sum test, or chi-square test. 
TMA, thigh muscle area; Wt, weight; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assess-
ment of insulin resistance; IR, insulin resistance.
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by adjusting for risk factors, including central obesity, but also by 
stratifying by sex, menopausal status, and overall obesity status. 
The underlying mechanisms of the association between low 
muscle mass and higher IR are not fully understood. One of 
the potential explanations is that muscle tissue is the primary 
tissue responsible for insulin-mediated glucose disposal; hence, 
Table 3. Characteristics in postmenopausal women (n=1,476) according to TMA/Wt tertiles
Variable
TMA/Wt tertiles P for 
difference
P for 
trendLower (<261.0 cm2/kg) Middle (261.0–292.4 cm2/kg) Upper (≥292.5 cm2/kg)
Age, yr 57.6±3.9 57.0±3.9 56.7±4.4 0.001 <0.001
BMI, kg/m2 25.3±3.1 23.5±2.4 22.4±2.0 <0.001 <0.001
Waist circumference, cm 83.3±8.2 79.3±6.8 75.1±6.1 <0.001 <0.001
Visceral fat area, cm2 115.90±40.40 99.30±36.30 79.90±30.90 <0.001 <0.001
SBP, mm Hg 119.9±14.9 117.7±14.8 114.8±13.2 <0.001 <0.001
DBP, mm Hg 76.1±9.0 75.0±9.1 73.2±8.3 <0.001 <0.001
Total cholesterol, mg/dL 209.1±36.0 208.8±35.8 203.8±33.2 0.031 0.155
HDL-C, mg/dL 59.3±13.6 59.4±13.6 62.2±15.0 0.001 0.056
LDL-C, mg/dL 128.0±32.0 125.7±33.1 121.2±31.3 0.028 0.019
Triglycerides, mg/dL 116.5 (86.0–150.0) 108.0 (84.0–143.0) 98.0 (72.0–137.5) <0.001 0.022
Fasting glucose, mg/dL 89.0 (84.0–95.5) 88.0 (82.0–94.0) 87.0 (82.0–93.0) <0.001 <0.001
Fasting insulin, uIU/mL 8.6 (7.0–11.0) 8.0 (6.4–10.3) 7.5 (5.8–9.5) <0.001 <0.001
HbA1c, % 5.7 (5.4–6.0) 5.6 (5.4–5.9) 5.6 (5.4–5.8) 0.008 <0.001
HOMA-IR 1.89 (1.50–2.59) 1.74 (1.35–2.29) 1.58 (1.25–2.12) <0.001 <0.001
Increased IR, % 160 (32.5) 118 (24.0) 91 (18.5) <0.001 <0.001
C-reactive protein, mg/L 0.8 (0.4–1.7) 0.6 (0.4–1.1) 0.5 (0.3–0.9) <0.001 0.011
Hypertension 159 (32.3) 131 (26.6) 105 (21.3) <0.001 <0.001
Pre-diabetes mellitus 238 (48.4) 199 (40.5) 214 (43.5) 0.041 0.123
Dyslipidemia 254 (51.6) 233 (47.4) 195 (39.6) <0.001 <0.001
Antihypertensive medication 115 (23.4) 83 (16.9) 84 (17.1) 0.013 0.012
Lipid-lowering medication 88 (17.9) 79 (16.1) 80 (16.3) 0.701 0.495
Smoking status 0.511 0.599
   Non-smoker 469 (95.3) 476 (96.8) 471 (95.7)
   Former smoker 15 (3.1) 12 (2.4) 11 (2.2)
   Current smoker 8 (1.6) 4 (0.8) 10 (2.0)
Alcohol intake 0.002 0.012
   Non-drinker 205 (36.0) 174 (35.9) 121 (28.7)
   Former drinker 17 (3.0) 19 (3.9) 9 (2.1)
   Current non-heavy drinker 317 (55.7) 272 (56.1) 251 (59.5)
   Current heavy drinker 30 (2.3) 20 (4.1) 41 (9.7)
Regular exercise 326 (66.3) 332 (67.5) 355 (72.2) 0.109 0.046
Sleep duration, hr/day 6.8±1.2 6.8±1.2 6.8±1.3 0.802 0.507
Values are presented as mean±standard deviation, median (interquartile range), or number (%). P values were derived using the independent t-
test, Wilcoxon rank sum test, or chi-square test. 
TMA, thigh muscle area; Wt, weight; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assess-
ment of insulin resistance; IR, insulin resistance.
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Table 4. Association between TMA/Wt and increased IR in men and premenopausal and postmenopausal women
Subgroup No. of participants No. of cases (%)
OR (95% CI)
Model 1 Model 2 Model 3
Men 
   Upper tertile 421 54 (12.8) 1.00 1.00 1.00
   Middle tertile 421 92 (21.9) 1.98 (1.37–2.87) 1.67 (1.14–2.45) 1.05 (0.70–1.58)
   Lower tertile 421 170 (40.4) 4.79 (3.38–6.79) 3.87 (2.70–5.55) 1.63 (1.10–2.45)
   Per 10 cm2/kg lower 1,263 316 (25.0) 1.18 (1.14–1.22) 1.16 (1.12–1.20) 1.06 (1.02–1.10)
Premenopausal women
   Upper tertile 263 42 (16.0) 1.00 1.00 1.00
   Middle tertile 263 73 (27.8) 2.02 (1.32–3.10) 1.97 (1.26–3.07) 1.15 (0.70–1.88)
   Lower tertile 262 82 (31.3) 2.39 (1.57–3.65) 1.99 (1.27–3.11) 1.00 (0.58–1.60)
   Per 10 cm2/kg lower 788 197 (25.0) 1.12 (1.08–1.17) 1.10 (1.05–1.15) 1.01 (0.95–1.06)
Postmenopausal women
   Upper tertile 492 91 (18.5) 1.00 1.00 1.00
   Middle tertile 492 118 (24.0) 1.38 (1.02–1.88) 1.21 (0.88–1.66) 0.76 (0.54–1.08)
   Lower tertile 492 160 (32.5) 2.08 (1.54–2.79) 1.81 (1.32–2.47) 0.77 (0.54–1.10)
   Per 10 cm2/kg lower 1,476 369 (25.0) 1.08 (1.05–1.11) 1.07 (1.04–1.10) 0.97 (0.93–1.01)
Model 1, adjusted for age; Model 2, adjusted for variables in Model 1 plus systolic blood pressure, triglyceride level, smoking, alcohol intake, reg-
ular exercise, and sleep duration; Model 3, adjusted for variables in Model 2 plus visceral fat.
TMA, thigh muscle area; Wt, weight; IR, insulin resistance; OR, odds ratio; CI, confidence interval.
Table 5. Association between TMA/Wt and increased IR according to BMI categorization in men
BMI No. of participants No. (%) of cases
OR (95% CI)
Model 1 Model 2 Model 3
BMI <25 kg/m2
   Upper tertile 227 12 (5.3) 1.00 1.00 1.00
   Middle tertile 228 32 (14.0) 2.93 (1.46–5.85) 2.58 (1.26–5.28) 1.84 (0.88–3.84)
   Lower tertile 227 36 (15.9) 3.38 (1.70–6.70) 3.15 (1.57–6.34) 1.59 (0.75–3.40)
   Per 10 cm2/kg lower 682 80 (11.7) 1.10 (1.04–1.17) 1.10 (1.03–1.16) 1.02 (0.95–1.09)
BMI ≥25 kg/m2
   Upper tertile 194 52 (26.8) 1.00 1.00 1.00
   Middle tertile 194 71 (36.6) 1.59 (1.03–2.45) 1.54 (0.98–2.43) 1.08 (0.66–1.74)
   Lower tertile 193 113 (58.6) 3.89 (2.53–5.97) 3.73 (2.39–5.85) 2.31 (1.42–3.74)
   Per 10 cm2/kg lower 581 236 (40.6) 1.16 (1.11–1.21) 1.15 (1.10–1.20) 1.09 (1.03–1.15)
Model 1, adjusted for age; Model 2: adjusted for variables in Model 1 plus systolic blood pressure, triglyceride level, smoking, alcohol intake, reg-
ular exercise, and sleep duration; Model 3, adjusted for variables in Model 2 plus visceral fat.
TMA, thigh muscle area; Wt, weight; IR, insulin resistance; BMI, body mass index; OR, odds ratio; CI, confidence interval. 
a low muscle mass could cause a decreased insulin-mediated 
glucose disposal, followed by higher IR. Another explanation 
could be in lifestyle factors, including smoking, alcohol intake, 
and physical activity. In the present study, after adjusting for 
these lifestyle factors, ORs were slightly weakened, but still re-
mained significant in men. This suggested that lifestyle factors 
might partially, but not fully, explain the association between 
low muscle mass and higher IR. In the current study, according 
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to stratification analyses by BMI categories, a significant in-
verse association was only observed in men with higher BMIs. 
Interestingly, while age-related muscle loss has been shown to 
be due to a reduction in muscle fibers and fiber atrophy [30], 
participants with obesity [31-33], particularly men [34], also 
have increased ceramides in their muscle fibers, as well as few-
er muscle fibers, which plays an important role in IR. 
In women, regardless of menopausal status, the significant 
association disappeared after adjusting for the visceral fat area. 
This finding could suggest that the differences in body compo-
sition between men and women may modify the relationship 
between muscle and IR. First, age-related decreases in skeletal 
muscle mass and muscle strength are inevitable in both men 
and women; however, they are more prominent in men than in 
women [12]. This could be affected by the sex-specific effects 
of sex hormones. In men, testosterone levels generally control 
changes in skeletal muscle mass, and in women, there is much 
less of an absolute decline in testosterone levels with aging than 
that in men. Thus, women may not experience the effects of 
testosterone decline on skeletal muscle mass. Additionally, fe-
male sex hormones, especially estrogen, have been found to 
provide protective effects on adipocyte inflammation, oxida-
tive stress, and IR in an animal study [35]. Second, fat distribu-
tions are different between men and women. Adipose tissue 
primarily accumulates around the trunk and abdomen in men, 
but around the hips and thighs in women [36,37]. According 
to previous studies, although the absolute amount of visceral 
fat area is higher in men than in women, the risk of visceral fat 
area on cardiometabolic abnormalities is higher in women 
than in men [38]. A possible reason for this is that the thigh 
muscle might have a relatively smaller impact on the IR in 
women than in men [39], due to the preexisting risk of fat on 
metabolic imbalance [40]. In this regard, women would likely 
be less affected by muscle declines than men. 
After stratification according to menopausal status, lower 
thigh muscle tended to be associated with higher IR in pre-
menopausal women, whereas higher thigh muscle was tended 
to be associated with higher IR in postmenopausal women. 
Nevertheless, both of these trends were not significant. Instead 
of thigh muscle mass, age and visceral fat area were significant-
ly associated with increased IR in premenopausal women, 
while blood pressure, triglycerides, and visceral fat area were 
significantly associated with increased IR in postmenopausal 
women (Supplementary Table 3). Several previous studies [41-
43] have reported that postmenopausal women have greater 
abdominal fat, higher blood pressure, higher lipid profiles than 
premenopausal women even after adjustment for age, and 
these risk factors could have great harmful impact on higher 
IR than protective effect of greater muscle mass. Further stud-
ies are needed to confirm which ways associations differ be-
tween premenopausal and postmenopausal women, as well as 
between men and women.
The current study had a few limitations. First, TMA was 
measured using QCT, but more detailed characteristics such as 
thigh intramuscular or intermuscular fat content were not 
measured. Previous research has indicated that there are sex 
differences in mid-thigh composition, such as muscle density, 
which is a marker of muscle fat infiltration [44,45]. Although 
fat infiltration in a muscle accounts for a relatively small por-
tion of the muscle, not considering muscle fat infiltration may 
not represent the muscles of women well. Second, we used 
HOMA-IR as a surrogate marker for IR. However, it is fre-
quently used for assessing IR in large population-based stud-
ies, because it takes minimal time, is not invasive, and shows 
excellent predictability for IR [46]. Third, both the thigh mus-
cle and IR were measured only once; therefore, we cannot ex-
clude the possibility of random measurement errors that might 
have weakened the observed association. Fourth, we might not 
have completely accounted for all residual confounders. Final-
ly, this study was cross-sectional in nature; therefore, a causal 
association between low thigh muscle mass and higher IR is 
uncertain.
In conclusion, we found an association between lower thigh 
muscle mass and higher IR in men, particularly those with 
higher BMIs, but not in those with lower BMIs, even after ad-
justing for traditional risk factors. Our findings suggest that 
the maintenance of both an appropriate BMI and thigh muscle 
is important for normal IR in middle-aged Korean men. 
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